Article Details

Healthtech unicorn PharmEasy to acquire 66% stake in publicly listed diagnostics major Thyrocare

Retrieved on: 2021-06-28 03:22:30

Tags for this article:

Click the tags to see associated articles and topics

Healthtech unicorn PharmEasy to acquire 66% stake in publicly listed diagnostics major Thyrocare. View article details on hiswai:

Excerpt

The deal, while big o paper, also signifies India's rapidly evolving health-tech space, considering how a startup gets to acquire a listed, over 3 decades ...

Article found on: thetechportal.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up